161 related articles for article (PubMed ID: 10982799)
1. Definition of the p53 functional domains necessary for inducing apoptosis.
Zhu J; Zhang S; Jiang J; Chen X
J Biol Chem; 2000 Dec; 275(51):39927-34. PubMed ID: 10982799
[TBL] [Abstract][Full Text] [Related]
2. The activation domains, the proline-rich domain, and the C-terminal basic domain in p53 are necessary for acetylation of histones on the proximal p21 promoter and interaction with p300/CREB-binding protein.
Liu G; Xia T; Chen X
J Biol Chem; 2003 May; 278(19):17557-65. PubMed ID: 12609999
[TBL] [Abstract][Full Text] [Related]
3. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression.
Venot C; Maratrat M; Dureuil C; Conseiller E; Bracco L; Debussche L
EMBO J; 1998 Aug; 17(16):4668-79. PubMed ID: 9707426
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity.
Zhu J; Jiang J; Zhou W; Zhu K; Chen X
Oncogene; 1999 Mar; 18(12):2149-55. PubMed ID: 10321740
[TBL] [Abstract][Full Text] [Related]
5. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function.
Kong XT; Gao H; Stanbridge EJ
J Biol Chem; 2001 Aug; 276(35):32990-3000. PubMed ID: 11395510
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel p53 functional domain that is necessary for efficient growth suppression.
Walker KK; Levine AJ
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15335-40. PubMed ID: 8986812
[TBL] [Abstract][Full Text] [Related]
8. Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest.
Ryan KM; Vousden KH
Mol Cell Biol; 1998 Jul; 18(7):3692-8. PubMed ID: 9632751
[TBL] [Abstract][Full Text] [Related]
9. The C terminus of p53 family proteins is a cell fate determinant.
Harms KL; Chen X
Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel p53 functional domain that is necessary for mediating apoptosis.
Zhu J; Zhou W; Jiang J; Chen X
J Biol Chem; 1998 May; 273(21):13030-6. PubMed ID: 9582339
[TBL] [Abstract][Full Text] [Related]
11. Role of the ATPase domain of the Cockayne syndrome group B protein in UV induced apoptosis.
Balajee AS; Proietti De Santis L; Brosh RM; Selzer R; Bohr VA
Oncogene; 2000 Jan; 19(4):477-89. PubMed ID: 10698517
[TBL] [Abstract][Full Text] [Related]
12. Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.
Rowan S; Ludwig RL; Haupt Y; Bates S; Lu X; Oren M; Vousden KH
EMBO J; 1996 Feb; 15(4):827-38. PubMed ID: 8631304
[TBL] [Abstract][Full Text] [Related]
13. The proline-rich region of mouse p53 influences transactivation and apoptosis but is largely dispensable for these functions.
Edwards SJ; Hananeia L; Eccles MR; Zhang YF; Braithwaite AW
Oncogene; 2003 Jul; 22(29):4517-23. PubMed ID: 12881708
[TBL] [Abstract][Full Text] [Related]
14. Characterization of p73 functional domains necessary for transactivation and growth suppression.
Nozell S; Wu Y; McNaughton K; Liu G; Willis A; Paik JC; Chen X
Oncogene; 2003 Jul; 22(28):4333-47. PubMed ID: 12853970
[TBL] [Abstract][Full Text] [Related]
15. The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.
Baptiste N; Friedlander P; Chen X; Prives C
Oncogene; 2002 Jan; 21(1):9-21. PubMed ID: 11791172
[TBL] [Abstract][Full Text] [Related]
16. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.
Dohn M; Zhang S; Chen X
Oncogene; 2001 May; 20(25):3193-205. PubMed ID: 11423969
[TBL] [Abstract][Full Text] [Related]
17. Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain.
Roth J; Koch P; Contente A; Dobbelstein M
Oncogene; 2000 Mar; 19(14):1834-42. PubMed ID: 10777217
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Bax activation and apoptotic response to microtubule-damaging agents by p53 transcription-dependent and -independent pathways.
Yamaguchi H; Chen J; Bhalla K; Wang HG
J Biol Chem; 2004 Sep; 279(38):39431-7. PubMed ID: 15262986
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
Ramondetta L; Mills GB; Burke TW; Wolf JK
Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
[TBL] [Abstract][Full Text] [Related]
20. bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity.
D'Sa-Eipper C; Subramanian T; Chinnadurai G
Cancer Res; 1996 Sep; 56(17):3879-82. PubMed ID: 8752150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
